[Cetuximab plus chemoradiotherapy for anal carcinoma in immunocompetent patients does not change existing therapy standards : Results from the prospective, multicenter E3205 trial].
作者信息
Nieder Carsten
机构信息
Dept. of Oncology and Palliative Medicine, Nordland Hospital Trust, Prinsensgate 164, P.O. Box 1480, 8092, Bodø, Norwegen.
出版信息
Strahlenther Onkol. 2017 Jun;193(6):508-509. doi: 10.1007/s00066-017-1133-x.
PMID:28409247
Abstract
摘要
Zotero 插件